New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies
Molecules · 2024
DOI: 10.3390/molecules29112510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Rachid Bouzammit und 11 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Laboratory of Organometallic and Molecular Materials and Environment, Faculty of Sciences Dhar El Mahraz, University Sidi Mohamed Ben Abd…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Triazoles, Molecular Docking Simulation, Microbial Sensitivity Tests. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Researchers Supporting Project number (RSPD2024R628), King Saud University, Riyadh, Saudi Arabia, King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Novel isoxazole–triazole conjugates have been efficiently synthesized using 3-formylchromone as starting material according to a multi-step synthetic approach. The structures of the target conjugates and intermediate products were characterized by standard spectroscopic techniques (1H NMR and 13C NMR) and confirmed by mass spectrometry (MS). The all-synthesized compounds were screened for their antibacterial activity against three ATCC reference strains, namely Staphylococcus aureus ATCC 25923, Staphylococcus aureus ATCC BAA-44, and Escherichia coli ATCC 25922 as well as one strain isolated from the hospital environment Pseudomonas aeruginosa. The findings indicate that conjugate 7b exhibits a stronger antibacterial response against the tested Escherichia coli ATCC 25922 and Pseudomonas aeruginosa pathogenic strains compared to the standard antibiotics. Furthermore, hybrid compound 7b proved to have a bactericidal action on the Escherichia coli ATCC 25922 strain, as evidenced by the results of the MBC determination. Moreover, the ADMET pharmacokinetic characteristics revealed a favorable profile for the examined compound, as well as a good level of oral bioavailability. Molecular docking and molecular dynamics simulations were performed to explore the inhibition mechanism and binding energies of conjugate 7b with the proteins of Escherichia coli and Pseudomonas aeruginosa bacterial strains. The in silico results corroborated the data observed in the in vitro evaluation for compound 7b.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Laboratory of Organometallic and Molecular Materials and Environment, Faculty of Sciences Dhar El Mahraz, University Sidi Mohamed Ben Abdellah, P.O. Box 1796, Atlas, Fez 30000, Morocco.
- Laboratory of Epidemiology and Research in Health Sciences, Faculty of Medicine, Pharmacy and Dentistry, University Sidi Mohammed Ben Abdellah, Fez 30070, Morocco.
- LIMAS Laboratory, Chemistry Department, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, P.O. Box 1796, Atlas, Fez 30000, Morocco.
- Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Laboratory of Materials Engineering for the Environment and Natural Ressources, Faculty of Sciences and Techniques, University of Moulay Ismail of Meknès, B.P 509, Boutalamine, Errachidia 52000, Morocco.
ORCID-Profile: Salim Belchkar, Mohamed El Fadili, Youssra Kanzouai, Somdutt Mujwar, Mohammed M Alanazi, Mohammed Chalkha, Mohamed Bakhouch, Emese Gal, Luiza Ioana Gaina, Ghali Al Houari
Förderung
- the Researchers Supporting Project number (RSPD2024R628), King Saud University, Riyadh, Saudi Arabia
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Bouzammit, R., Belchkar, S., El Fadili, M., Kanzouai, Y., Mujwar, S., Alanazi, M. M., Chalkha, M., Nakkabi, A., Bakhouch, M., Gal, E., Gaina, L. I., & Al Houari, G. (2024). New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies. Molecules. https://doi.org/10.3390/molecules29112510
Vancouver
Bouzammit R, Belchkar S, El Fadili M, Kanzouai Y, Mujwar S, Alanazi MM, et al. New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies. Molecules. 2024. doi:10.3390/molecules29112510
BibTeX
@article{Bouzammit2024,
author = {Bouzammit, Rachid and Belchkar, Salim and El Fadili, Mohamed and Kanzouai, Youssra and Mujwar, Somdutt and Alanazi, Mohammed M and Chalkha, Mohammed and Nakkabi, Asmae and Bakhouch, Mohamed and Gal, Emese and Gaina, Luiza Ioana and Al Houari, Ghali},
title = {New Triazole-Isoxazole Hybrids as Antibacterial Agents: Design, Synthesis, Characterization, In Vitro, and In Silico Studies},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112510}
}
EUVIMED